Age-related modulation of γ-secretase activity in non-human primate brains

Journal of Neurochemistry

Volumn 123, Issue 1, 2012, Pages 21-28

  Nishimura, Masaki ^a   Nakamura, Shin Ichiro ^a   Kimura, Nobuyuki ^b   Liu, Lei ^a   Suzuki, Toshiharu ^c   Tooyama, Ikuo ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

secretase; aging; Alzheimer's disease; amyloid peptide; cynomolgus monkey

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; GAMMA SECRETASE;

AGE; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN MICROSOME; CELL FREE SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; FEMALE; HAPLORHINI; HISTOLOGY; MALE; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

AGE FACTORS; AGING; AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; FEMALE; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; MACACA FASCICULARIS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICROSOMES; PEPTIDE HYDROLASES; PRESENILIN-1; PRESENILIN-2; TEMPORAL LOBE; TRANSFECTION;

MACACA FASCICULARIS; PRIMATES;

EID: 84866251591     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07884.x     Document Type: Article

References (39)

1. Bentahir M., Nyabi O., Verhamme J., Tolia A., Horre K., Wiltfang J., Esselmann H., and, De Strooper B., (2006) Presenilin clinical mutations can affect γ-secretase activity by different mechanisms. J. Neurochem. 96, 732-742.
2. Borchelt D. R., Ratovitski T., van Lare J., Lee M. K., Gonzales V., Jenkins N. A., Copeland N. G., Price D. L., and, Sisodia S. S., (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19, 939-945. (Pubitemid 27471397)
3. Caccamo A., Oddo S., Sugarman M. C., Akbari Y., and, LaFerla F. M., (2005) Age- and region-dependent alterations in Aβ-degrading enzymes: implications for Aβ-induced disorders. Neurobiol. Aging 26, 645-654. (Pubitemid 40228756)
4. Fukumoto H., Rosene D. L., Moss M. B., Raju S., Hyman B. T., and, Irizarry M. C., (2004) β-secretase activity increases with aging in human, monkey, and mouse brain. Am. J. Pathol. 164, 719-725. (Pubitemid 38364685)
5. Funato H., Yoshimura M., Kusui K., Tamaoka A., Ishikawa K., Ohkoshi N., Namekata K., Okeda R., and, Ihara Y., (1998) Quantitation of amyloid β-protein (Aβ) in the cortex during aging and in Alzheimer's disease. Am. J. Pathol. 152, 1633-1640. (Pubitemid 28275021)
6. Geula C., Wu C. K., Saroff D., Lorenzo A., Yuan M., and, Yankner B. A., (1998) Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nat. Med. 4, 827-831. (Pubitemid 28331025)
7. Geula C., Nagykery N., and, Wu C. K., (2002) Amyloid-β deposits in the cerebral cortex of the aged common marmoset (Callithrix jacchus): incidence and chemical composition. Acta Neuropathol. 103, 48-58. (Pubitemid 36075312)
8. Hardy J., and, Selkoe D. J., (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
9. Hata S., Fujishige S., Araki Y., et al. (2011) Alternative processing of γ-secretase substrates in common forms of mild cognitive impairment and Alzheimer's disease: evidence for γ-secretase dysfunction. Ann. Neurol. 69, 1026-1031.
10. Isoo N., Sato C., Miyashita H., Shinohara M., Takasugi N., Morohashi Y., Tsuji S., Tomita T., and, Iwatsubo T., (2007) Aβ42 overproduction associated with structural changes in the catalytic pore of γ-secretase: common effects of Pen-2 N-terminal elongation and fenofibrate. J. Biol. Chem. 282, 12388-12396. (Pubitemid 47100594)
11. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., and, Ihara Y., (1994) Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron, 13, 45-53.
12. Jorm A. F., Korten A. E., and, Henderson A. S., (1987) The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr. Scand. 76, 465-479. (Pubitemid 17164786)
13. Kim J., Basak J. M., and, Holtzman D. M., (2009) The role of apolipoprotein E in Alzheimer's disease. Neuron 63, 287-303.
14. Kimura N., Tanemura K., Nakamura S., Takashima A., Ono F., Sakakibara I., Ishii Y., Kyuwa S., and, Yoshikawa Y., (2003) Age-related changes of Alzheimer's disease-associated proteins in cynomolgus monkey brains. Biochem. Biophys. Res. Commun. 310, 303-311. (Pubitemid 37163664)
15. Kukar T., Murphy M. P., Eriksen J. L., et al. (2005) Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Aβ42 production. Nat. Med. 11, 545-550. (Pubitemid 40685978)
16. de Magalhaes J. P., Costa J., and, Church G. M., (2007) An analysis of the relationship between metabolism, developmental schedules, and longevity using phylogenetic independent contrasts. J. Gerontol. A Biol. Sci. Med. Sci. 62, 149-160. (Pubitemid 47065738)
17. Marotti K. R., Whitted B. E., Castle C. K., Polites H. G., and, Melchior G. W., (1989) Nucleotide sequence of the cynomolgus monkey apolipoprotein E cDNA. Nucleic Acids Res. 17, 1778. (Pubitemid 19065154)
18. McGowan E., Pickford F., Kim J., et al. (2005) Aβ42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47, 191-199. (Pubitemid 41019251)
19. Mestre-Frances N., Keller E., Calenda A., Barelli H., Checler F., and, Bons N., (2000) Immunohistochemical analysis of cerebral cortical and vascular lesions in the primate Microcebus murinus reveal distinct amyloid β1-42 and β1-40 immunoreactivity profiles. Neurobiol. Dis. 7, 1-8. (Pubitemid 30141815)
20. Mitsuishi Y., Hasegawa H., Matsuo A., et al. (2010) Human CRB2 inhibits γ-secretase cleavage of amyloid precursor protein by binding to the presenilin complex. J. Biol. Chem. 285, 14920-14931.
21. Morishima-Kawashima M., Oshima N., Ogata H., Yamaguchi H., Yoshimura M., Sugihara S., and, Ihara Y., (2000) Effect of apolipoprotein E allele ε4 on the initial phase of amyloid β-protein accumulation in the human brain. Am. J. Pathol. 157, 2093-2099.
22. Morris J. C., Roe C. M., Xiong C., Fagan A. M., Goate A. M., Holtzman D. M., and, Mintun M. A., (2010) APOE predicts amyloid-β but not tau Alzheimer pathology in cognitively normal aging. Ann. Neurol. 67, 122-131.
23. Nagahara A. H., Bernot T., and, Tuszynski M. H., (2010) Age-related cognitive deficits in rhesus monkeys mirror human deficits on an automated test battery. Neurobiol. Aging 31, 1020-1031.
24. Nakamura S., Tamaoka A., Sawamura N., et al. (1995) Carboxyl end-specific monoclonal antibodies to amyloid β protein (Aβ) subtypes (Aβ40 and Aβ42(43)) differentiate Aβ in senile plaques and amyloid angiopathy in brains of aged cynomolgus monkeys. Neurosci. Lett. 201, 151-154.
25. Placanica L., Tarassishin L., Yang G., Peethumnongsin E., Kim S. H., Zheng H., Sisodia S. S., and, Li Y. M., (2009a) Pen2 and presenilin-1 modulate the dynamic equilibrium of presenilin-1 and presenilin-2 γ-secretase complexes. J. Biol. Chem. 284, 2967-2977.
26. Placanica L., Zhu L., and, Li Y. M., (2009b) Gender- and age-dependent γ-secretase activity in mouse brain and its implication in sporadic Alzheimer disease. PLoS ONE 4, e5088.
27. Podlisny M. B., Tolan D. R., and, Selkoe D. J., (1991) Homology of the amyloid β protein precursor in monkey and human supports a primate model for β amyloidosis in Alzheimer's disease. Am. J. Pathol. 138, 1423-1435.
28. Price J. L., McKeel Jr D. W., Buckles V. D., et al. (2009) Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol. Aging 30, 1026-1036.
29. Qi-Takahara Y., Morishima-Kawashima M., Tanimura Y., et al. (2005) Longer forms of amyloid β protein: implications for the mechanism of intramembrane cleavage by γ-secretase. J. Neurosci. 25, 436-445. (Pubitemid 40105614)
30. Quintero-Monzon O., Martin M. M., Fernandez M. A., Cappello C. A., Krzysiak A. J., Osenkowski P., and, Wolfe M. S., (2011) Dissociation between the processivity and total activity of γ-secretase: implications for the mechanism of Alzheimer's disease-causing presenilin mutations. Biochemistry 50, 9023-9035.
31. Saito T., Suemoto T., Brouwers N., et al. (2011) Potent amyloidogenicity and pathogenicity of Aβ43. Nat. Neurosci. 14, 1023-1032.
32. Sani S., Traul D., Klink A., Niaraki N., Gonzalo-Ruiz A., Wu C. K., and, Geula C., (2003) Distribution, progression and chemical composition of cortical amyloid-β deposits in aged rhesus monkeys: similarities to the human. Acta Neuropathol. 105, 145-156. (Pubitemid 36798800)
33. Serneels L., Van Biervliet J., Craessaerts K., et al. (2009) γ-Secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer's disease. Science 324, 639-642.
34. Storandt M., Mintun M. A., Head D., and, Morris J. C., (2009) Cognitive decline and brain volume loss as signatures of cerebral amyloid-β peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Aβ deposition. Arch. Neurol. 66, 1476-1481.
35. Takami M., Nagashima Y., Sano Y., Ishihara S., Morishima-Kawashima M., Funamoto S., and, Ihara Y., (2009) γ-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of β-carboxyl terminal fragment. J. Neurosci. 29, 13042-13052.
36. Uchida K., Nakayama H., and, Goto N., (1991) Pathological studies on cerebral amyloid angiopathy, senile plaques and amyloid deposition in visceral organs in aged dogs. J. Vet. Med. Sci. 53, 1037-1042.
37. Villemagne V. L., Pike K. E., Chetelat G., et al. (2011) Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. Ann. Neurol. 69, 181-192.
38. Wisniewski H. M., Ghetti B., and, Terry R. D., (1973) Neuritic (senile) plaques and filamentous changes in aged rhesus monkeys. J. Neuropathol. Exp. Neurol. 32, 566-584.
39. Yanagida K., Okochi M., Tagami S., et al. (2009) The 28-amino acid form of an APLP1-derived Aβ-like peptide is a surrogate marker for Aβ42 production in the central nervous system. EMBO Mol. Med. 1, 223-235.